By Editor , 30 September 2026
DuPont Launches Digital Advisor for Sugar Separation Resin Selection

Wilmington – September 30, 2026 -- DuPont has launched the Sugar Separation Advisor, a digital tool that helps sugar and sweetener manufacturers identify candidate DuPontTM AmberLiteTM chromatography resins for food and beverage ingredient production.

By Editor , 30 September 2026
Quantum Space Taps All Points Logistics for Prime Mission Launch Prep

Rockville, Md. – – September 30, 2026 -- Quantum Space, LLC has signed a mission-specific work order with All Points Logistics, LLC to handle spacecraft processing, propellant servicing and launch-site operations for its Prime mission at Vandenberg Space Force Base in California, targeting a launch in the second half of 2027.

By Editor , 30 September 2026
63% of Consumers Would Let AI Pick Brands for a 20% Discount

Durham, N.C. – September 30, 2026 -- Sixty-three percent of U.S. adults said they would or might let an AI shopping assistant choose brands on their behalf if it consistently saved them 20% on purchases, according to a nationwide survey of 2,000 Americans conducted by Talker Research on behalf of payments platform Spreedly.

The findings arrive as AI shopping agents, including Meta's newly launched Muse, expand from product discovery into checkout, intensifying scrutiny over how much purchasing authority consumers will cede to automated systems.

By Editor , 30 September 2026
Sidero Labs Launches Talos Director as VMware Alternative

Santa Barbara, Calif. – September 30, 2026 -- Sidero Labs launched Talos Director, a single management platform positioned as a direct alternative to VMware for enterprises migrating virtual machines and Kubernetes clusters off legacy virtualization stacks. The platform is now in Limited Availability, with general availability planned for January 2027.

By Editor , 30 September 2026
ProphetX Taps Plaee to Scale Distribution for Regulated Sports Prediction Markets

New York – September 30, 2026 -- ProphetX, described as America's first federally regulated sports-native prediction market, has signed a technology partnership with Plaee to give distribution operators a single integration point into its CFTC-regulated exchange, avoiding custom builds for each new partner.

By Editor , 30 September 2026
Pierre Fabre Resubmits FDA BLA for Tabelecleucel in Rare Post-Transplant Cancer

Secaucus, N.J. – September 30, 2026 -- Pierre Fabre Pharmaceuticals Inc. (PFP) has resubmitted a Biologics License Application to the U.S. Food and Drug Administration for tabelecleucel, seeking approval as a monotherapy for adult and pediatric patients aged 2 and older with relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed at least one prior therapy.